Clinical Trial Update: Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of sequential whole lung lavage followed by inhaled GM-CSF for autoimmune pulmonary alveolar proteinosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Alveolar Proteinosis

Drugs mentioned

• GM-CSF inhalation (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Dai Huaping | Conditions: Pulmonary Alveolar Proteinosis, Treatment | Phase 2 | Status: UNKNOWN